NCT04851119 2026-02-24
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Children's Oncology Group
Phase 1/2 Recruiting
Clinical Trials
14 trialsNCT01730937 2026-01-28
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT06880523 2025-12-18
SLIDE-HCC
Canadian Cancer Trials Group
Phase 2 Recruiting
NCT02511522 2024-10-23
Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
Canadian Cancer Trials Group
Phase NA Completed
NCT00095992 2023-08-04
SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT00658593 2023-08-04
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Canadian Cancer Trials Group
Phase 3 Terminated
NCT01082224 2023-07-07
ACRIN6690
American College of Radiology Imaging Network
Phase NA Unknown
NCT05935189 2023-07-07
TIR-HCC
Nikomed Medical Center
Recruiting
NCT00003907 2023-07-05
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00132041 2020-09-10
ACRIN-6673
American College of Radiology Imaging Network
Phase NA Completed
NCT04538313 2020-09-04
A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs
CAR-T (Shanghai) Cell Biotechnology Co., Ltd.
Phase 1/2 Unknown
NCT00016380 2020-04-03
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
Canadian Cancer Trials Group
Phase 3 Completed
NCT01834963 2018-05-18
P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.
Kansai Hepatobiliary Oncology Group
Phase 2 Unknown
NCT00030511 2012-07-16
Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated